Search - tctmd.com

Displaying 361 - 380 of 1897

Sort: Relevancy | Date

News Industry News

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

Presentation TCT 2015

I Dont Believe Multivessel Revascularization Should Routinely Be Performed During the Index Primary PCI or Before Hospital Discharge!

Presenter: Nick Curzen, Ajay J. Kirtane, Shamir R. Mehta

October 12, 2015

Presentation TCT 2015

Combined Tibiopedal Access With Transcollateral Revascularization

Presenter: George L Adams, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

Transdigital Retrograde Access and Revascularization

Presenter: George L Adams, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

Combined Angio-CT as a Novel Imaging Modality for Improved Revascularization of Chronic Total Occlusions

Presenter: Charles E. Chambers, Giora Weisz, Patrick T Siegrist

October 12, 2015

Presentation TCT 2015

Spain Presents: A Case of iFR-FFR to Guide Coronary Revascularization in Multivessel Disease

Presenter: Morton J. Kern, Jan J. Piek, Javier Escaned

October 12, 2015

News Conference News TCT 2015

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

News Industry News

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

October 12, 2015

News Conference News TCT 2015

CT-Derived FFR Could Improve Efficiency of Referral to ICA

October 12, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

News Conference News TCT 2015

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

October 12, 2015

Presentation TCT 2015

Summary and Closing Remarks

Presenter: Alejandro Cherro, Arturo José Fernández Murga, Alfredo E. Rodriguez

October 11, 2015

Presentation TCT 2015

Cardiac Arrest Patients: Resuscitation to Revascularization

Presenter: Sreenivas Arramraju Kumar

October 11, 2015

Advertisement

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

I Dont Believe Multivessel Revascularization Should Routinely Be Performed During the Index Primary PCI or Before Hospital Discharge!

Combined Tibiopedal Access With Transcollateral Revascularization

Transdigital Retrograde Access and Revascularization

Combined Angio-CT as a Novel Imaging Modality for Improved Revascularization of Chronic Total Occlusions

Spain Presents: A Case of iFR-FFR to Guide Coronary Revascularization in Multivessel Disease

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

CT-Derived FFR Could Improve Efficiency of Referral to ICA

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

Summary and Closing Remarks

Cardiac Arrest Patients: Resuscitation to Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content